For: | Jeyaraman N, Jeyaraman M, Mariappan T, Muthu S, Ramasubramanian S, Sharma S, Santos GS, da Fonseca LF, Lana JF. Insights of gut-liver axis in hepatic diseases: Mechanisms, clinical implications, and therapeutic potentials. World J Gastrointest Pharmacol Ther 2024; 15(6): 98146 [PMID: 39534519 DOI: 10.4292/wjgpt.v15.i6.98146] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v15/i6/98146.htm |
Number | Citing Articles |
1 |
Shengnan Meng, Luonan Li, Shijie Yin, Yuxuan Zhao, Yaning Liu, Yuxi Zhang, Xiaolin Zhang, Fengxue Yu. The newly proposed dietary index for gut microbiota and its association with the risk of nonalcoholic fatty liver disease: the mediating role of body mass index. Diabetology & Metabolic Syndrome 2025; 17(1) doi: 10.1186/s13098-025-01801-w
|
2 |
Xia Niu, Ge Chang, Ning Xu, Rui Li, Bingyu Niu, Rui Mao, Shan Wang, Guiling Li, Jiandong Jiang, Lulu Wang. Vitamin A-Integrated Cinnamaldehyde Nanoemulsion: A Nanotherapeutic Approach To Counteract Liver Fibrosis via Gut–Liver Axis Modulation. ACS Nano 2025; 19(10): 10433 doi: 10.1021/acsnano.5c00136
|